Frontiers in Oncology (Jan 2022)
Factors Predicting Oncological Outcomes of Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma in Taiwan
- I-Hsuan Alan Chen,
- I-Hsuan Alan Chen,
- I-Hsuan Alan Chen,
- Chao-Hsiang Chang,
- Chao-Hsiang Chang,
- Chi-Ping Huang,
- Chi-Ping Huang,
- Wen-Jeng Wu,
- Wen-Jeng Wu,
- Wen-Jeng Wu,
- Ching-Chia Li,
- Ching-Chia Li,
- Ching-Chia Li,
- Chung-Hsin Chen,
- Chao-Yuan Huang,
- Chi-Wen Lo,
- Chih-Chin Yu,
- Chih-Chin Yu,
- Chung-You Tsai,
- Chung-You Tsai,
- Wei-Che Wu,
- Wei-Che Wu,
- Jen-Shu Tseng,
- Jen-Shu Tseng,
- Wun-Rong Lin,
- Wun-Rong Lin,
- Yuan-Hong Jiang,
- Yu-Khun Lee,
- Yeong-Chin Jou,
- Yeong-Chin Jou,
- Ian-Seng Cheong,
- Thomas Y. Hsueh,
- Thomas Y. Hsueh,
- Allen W. Chiu,
- Yung-Tai Chen,
- Jih-Sheng Chen,
- Bing-Juin Chiang,
- Bing-Juin Chiang,
- Bing-Juin Chiang,
- Yao-Chou Tsai,
- Yao-Chou Tsai,
- Wei Yu Lin,
- Wei Yu Lin,
- Wei Yu Lin,
- Chia-Chang Wu,
- Chia-Chang Wu,
- Chia-Chang Wu,
- Jen-Tai Lin,
- Chia-Cheng Yu
Affiliations
- I-Hsuan Alan Chen
- Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
- I-Hsuan Alan Chen
- Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
- I-Hsuan Alan Chen
- Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
- Chao-Hsiang Chang
- Department of Urology, China Medical University and Hospital, Taichung, Taiwan
- Chao-Hsiang Chang
- School of Medicine, China Medical University, Taichung, Taiwan
- Chi-Ping Huang
- Department of Urology, China Medical University and Hospital, Taichung, Taiwan
- Chi-Ping Huang
- School of Medicine, China Medical University, Taichung, Taiwan
- Wen-Jeng Wu
- Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
- Wen-Jeng Wu
- Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
- Wen-Jeng Wu
- Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
- Ching-Chia Li
- Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
- Ching-Chia Li
- Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
- Ching-Chia Li
- Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
- Chung-Hsin Chen
- Department of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan
- Chao-Yuan Huang
- Department of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan
- Chi-Wen Lo
- 0Division of Urology, Department of Surgery, Taipei Tzu Chi Hospital, The Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan
- Chih-Chin Yu
- 0Division of Urology, Department of Surgery, Taipei Tzu Chi Hospital, The Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan
- Chih-Chin Yu
- 1School of Medicine, Buddhist Tzu Chi University, Hualien, Taiwan
- Chung-You Tsai
- 2Division of Urology, Department of Surgery, Far Eastern Memorial Hospital, New Taipei, Taiwan
- Chung-You Tsai
- 3Department of Healthcare Information and Management, Ming Chuan University, Taipei, Taiwan
- Wei-Che Wu
- 2Division of Urology, Department of Surgery, Far Eastern Memorial Hospital, New Taipei, Taiwan
- Wei-Che Wu
- 4Institute of Biomedical Engineering, National Taiwan University, Taipei, Taiwan
- Jen-Shu Tseng
- 5Department of Urology, MacKay Memorial Hospital, Taipei, Taiwan
- Jen-Shu Tseng
- 6Department of Medicine, Mackay Medical College, Taipei, Taiwan
- Wun-Rong Lin
- 5Department of Urology, MacKay Memorial Hospital, Taipei, Taiwan
- Wun-Rong Lin
- 6Department of Medicine, Mackay Medical College, Taipei, Taiwan
- Yuan-Hong Jiang
- 7Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan
- Yu-Khun Lee
- 7Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan
- Yeong-Chin Jou
- 8Department of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, Taiwan
- Yeong-Chin Jou
- 9Department of Health and Nutrition Biotechnology, Asian University, Taichung, Taiwan
- Ian-Seng Cheong
- 8Department of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, Taiwan
- Thomas Y. Hsueh
- 0Division of Urology, Department of Surgery, Taipei City Hospital Renai Branch, Taipei, Taiwan
- Thomas Y. Hsueh
- 1Department of Urology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
- Allen W. Chiu
- 2College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
- Yung-Tai Chen
- 3Department of Urology, Taiwan Adventist Hospital, Taipei, Taiwan
- Jih-Sheng Chen
- 3Department of Urology, Taiwan Adventist Hospital, Taipei, Taiwan
- Bing-Juin Chiang
- 4College of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan
- Bing-Juin Chiang
- 5Department of Urology, Cardinal Tien Hospital, New Taipei City, Taiwan
- Bing-Juin Chiang
- 6Department of Life Science, College of Science, National Taiwan Normal University, Taipei, Taiwan
- Yao-Chou Tsai
- 7Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
- Yao-Chou Tsai
- 8Department of Urology, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan
- Wei Yu Lin
- 9Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Chia-Yi, Taiwan
- Wei Yu Lin
- 0Chang Gung University of Science and Technology, Chia-Yi, Taiwan
- Wei Yu Lin
- 1Department of Medicine, Chang Gung University, Taoyuan, Taiwan
- Chia-Chang Wu
- 7Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
- Chia-Chang Wu
- 2Department of Urology, Shuang Ho Hospital, Taipei Medical University, New Taipei, Taiwan
- Chia-Chang Wu
- 3TMU Research Center of Urology and Kidney, Taipei Medical University, Taipei, Taiwan
- Jen-Tai Lin
- Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
- Chia-Cheng Yu
- Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
- DOI
- https://doi.org/10.3389/fonc.2021.766576
- Journal volume & issue
-
Vol. 11
Abstract
BackgroundTaiwan is one of the endemic regions where upper tract urothelial carcinoma (UTUC) accounts for approximately a third of all urothelial tumors. Owing to its high prevalence, extensive experience has been accumulated in minimally invasive radical nephroureterectomy (RNU). Although a variety of predictive factors have been explored in numerous studies, most of them were on a single-center or limited institutional basis and data from a domestic cohort are lacking.ObjectiveThis study aims to identify significant predicting factors of oncological outcomes, including overall survival (OS), cancer-specific survival (CSS), disease-free survival (DFS), and intravesical recurrence-free survival (IVRFS), following RNU for UTUC in Taiwan.MethodsA multicenter registry database, Taiwan UTUC Collaboration Group, was utilized to analyze oncological outcomes of 3,333 patients undergoing RNU from 1988 to 2021 among various hospitals in Taiwan. Clinicopathological parameters were recorded according to the principles established by consensus meetings. The Kaplan-Meier estimator was utilized to estimate the survival rates, and the curves were compared using the stratified log-rank test. Univariate and multivariate analyses were performed with the Cox proportional hazard model to explore potential predicting factors.ResultsWith a median follow-up of 41.8 months in 1,808 patients with complete information, the 5-year IVRFS, DFS, CSS, and OS probabilities were 66%, 72%, 81%, and 70%, respectively. In total, 482 patients experienced intravesical recurrence, 307 died of UTUC, and 583 died of any cause. Gender predominance was female (57%). A total of 1,531 patients (84.7%) had high-grade tumors; preoperative hydronephrosis presented in 1,094 patients (60.5%). Synchronous bladder UC was identified in 292 patients (16.2%). Minimally invasive procedures accounted for 78.8% of all surgeries, including 768 hand-assisted laparoscopic (42.5%) and 494 laparoscopic (27.3%) approaches. Synchronous bladder UC was the dominant adverse predicting factor for all survival outcomes. Other independent predicting factors for OS, CSS, and DFS included age ≧70, presence of preoperative hydronephrosis, positive surgical margin, LVI, pathological T and N staging, and laparoscopic RNU.ConclusionSynchronous UC of the urinary bladder is an independent adverse prognostic factor for survival in UTUC. The presence of preoperative hydronephrosis was also corroborated as a disadvantageous prognostic factor. Our multivariate analysis suggested that laparoscopic RNU might provide better oncological control.
Keywords